Citation

Chang F. Canadian Pharmaceutical Journal 2005; 138(1): 31-36.

Copyright

(Copyright © 2005)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; aged; insomnia; psychotherapy; depression; mortality; comorbidity; pharmacist; patient education; polypharmacy; risk factor; review; sexual dysfunction; doxepin; amfebutamone; amitriptyline; citalopram; desipramine; fluoxetine; fluvoxamine; imipramine; mirtazapine; moclobemide; monoamine oxidase inhibitor; noradrenalin uptake inhibitor; nortriptyline; paroxetine; serotonin uptake inhibitor; sertraline; venlafaxine; neutropenia; somnolence; electroconvulsive therapy; gastrointestinal symptom; orthostatic hypotension; tranylcypromine; benzodiazepine derivative; trazodone; patient compliance; carbamazepine; nausea; weight gain; agranulocytosis; restlessness; maprotiline; theophylline; maintenance therapy; serotonin syndrome; infection; phenytoin; non prescription drug; drug half life; cytochrome P450; phenelzine; warfarin; anticholinergic effect; drug elimination; increased appetite; clarithromycin; geriatric depression scale; international normalized ratio; serotonin 2A antagonist